Atlas Trials

Melatonin for Prevention of Delirium in Critically Ill Patients

Clinical trial NCT02615340 · UNKNOWN

Trial details

NCT number
NCT02615340
Sponsor
Mount Sinai Hospital, Canada
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Delirium
Start date
2017-10-12
Primary completion
2018-10-12
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.